ArticleFrontiers in medicine2025
Multimodal approach to the diagnosis of pure neural neuropathy in leprosy.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Indoleamine 2,3-Dioxygenase: A Potential Biomarker for Neural Damage Severity of Leprosy Neuropathy.Cellular and molecular neurobiology · 2026Article
- Laboratory and functional tests in leprosy diagnosis: a practical guide for clinical decision-making.Anais brasileiros de dermatologiaReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Neuropathy is an important feature of leprosy, a chronic infection caused by Methods: Nerve conduction studies, ultrasound and histopathology by nerve biopsy (gold standard). Results: This study evaluated 29 cases that underwent peripheral nerve biopsy, which were then divided into positive or negative groups for pure neural form. The analysis sought to identify patterns that would help differentiate this form of leprosy, through clinical, electrophysiological and ultrasound evaluations. Of the 29 patients included, 13 were diagnosed with pure neural form and 16 were not. Discussion: The clinical features: sensory involvement occurred in all cases of confirmed pure neural form, while weakness was noted in the majority of cases in both groups, neural thickening was seen more frequently in the positive cases. Neurophysiology: sensory involvement was observed in all cases, motor involvement, a similar distribution was observed between the two groups (patterns were analyzed). On Ultrasound, neural thickening was observed in both groups, hypoechogenicity and heterogeneous fascicular disarray more frequent in the group with the diagnosis, flow in the Power Doppler in two patients only in pure neural form positive. There were no statistically significant differences in the clinical-electrophysiological and ultrasound analysis. With regard to the histopathological findings, bacilliferous findings were observed in 11 and inflammatory findings in 2. The characteristics of the negative cases were also analyzed. Pure neural leprosy remains a diagnostic challenge, especially in areas with limited resources. Histopathological examination remains the gold standard and, although non-invasive methods are desirable, they require rigorous validation to ensure accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.